Sara Matar

2.5k total citations
16 papers, 416 citations indexed

About

Sara Matar is a scholar working on Hematology, Molecular Biology and Neurology. According to data from OpenAlex, Sara Matar has authored 16 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Sara Matar's work include Chronic Myeloid Leukemia Treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Autophagy in Disease and Therapy (3 papers). Sara Matar is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Autophagy in Disease and Therapy (3 papers). Sara Matar collaborates with scholars based in United States, France and Palestinian Territory. Sara Matar's co-authors include Michaeline Hebron, Charbel Moussa, Yasar Torres‐Yaghi, Jaeil Ahn, Fernando Pagán, Barbara Wilmarth, Abigail Lawler, Elizabeth Mundel, Nadia Yusuf and Wangke Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Sara Matar

15 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Matar United States 9 164 113 102 95 55 16 416
Silke Metzger Germany 9 111 0.7× 82 0.7× 190 1.9× 247 2.6× 9 0.2× 12 534
Abhijeet Joshi Germany 11 46 0.3× 74 0.7× 115 1.1× 105 1.1× 26 0.5× 19 359
Eleonora Piras Italy 10 45 0.3× 42 0.4× 40 0.4× 277 2.9× 53 1.0× 13 597
Eun‐Mee Kim South Korea 6 80 0.5× 51 0.5× 63 0.6× 118 1.2× 17 0.3× 12 300
Kosuke Nakashima Japan 12 30 0.2× 52 0.5× 43 0.4× 263 2.8× 24 0.4× 25 620
D G Walker Canada 9 51 0.3× 146 1.3× 66 0.6× 149 1.6× 16 0.3× 9 487
Jiaqi Ding China 11 93 0.6× 53 0.5× 21 0.2× 173 1.8× 6 0.1× 35 400
Anne Willing Germany 11 78 0.5× 26 0.2× 22 0.2× 118 1.2× 14 0.3× 16 556
Bhim Singhal India 14 147 0.9× 65 0.6× 92 0.9× 236 2.5× 8 0.1× 21 506
Salvo Danilo Lombardo Italy 11 39 0.2× 32 0.3× 37 0.4× 138 1.5× 11 0.2× 22 359

Countries citing papers authored by Sara Matar

Since Specialization
Citations

This map shows the geographic impact of Sara Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Matar more than expected).

Fields of papers citing papers by Sara Matar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Matar. The network helps show where Sara Matar may publish in the future.

Co-authorship network of co-authors of Sara Matar

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Matar. A scholar is included among the top collaborators of Sara Matar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Matar. Sara Matar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2025). Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib. Journal of Clinical Medicine. 14(12). 4245–4245. 1 indexed citations
2.
Matar, Sara, et al.. (2024). Skin-brain dialogue in auto-inflammatory diseases: A new route to biomarkers?. Brain Behavior & Immunity - Health. 42. 100906–100906. 1 indexed citations
3.
Matar, Sara, et al.. (2024). Targetoid skin lesions in a newborn: a case of erythema multiforme. Oxford Medical Case Reports. 2024(11). omae145–omae145.
4.
Anderson, Karen E., et al.. (2022). Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington’s Disease Patients. Metabolites. 12(12). 1225–1225. 8 indexed citations
5.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2022). Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12296–e12296. 10 indexed citations
6.
Turner, Raymond Scott, Michaeline Hebron, Abigail Lawler, et al.. (2020). Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer’s disease: A phase 2, double‐blind, randomized, placebo‐controlled trial. Alzheimer s & Dementia. 16(S9). 1 indexed citations
7.
Turner, Raymond Scott, Michaeline Hebron, Abigail Lawler, et al.. (2020). Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease. Annals of Neurology. 88(1). 183–194. 82 indexed citations
8.
Pagán, Fernando, Barbara Wilmarth, Yasar Torres‐Yaghi, et al.. (2020). Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease. Movement Disorders. 36(3). 740–749. 38 indexed citations
9.
Matar, Sara, Bénédicte Oulès, Pierre Sohier, et al.. (2020). Cutaneous manifestations in SARS‐CoV‐2 infection (COVID‐19): a French experience and a systematic review of the literature. Journal of the European Academy of Dermatology and Venereology. 34(11). e686–e689. 50 indexed citations
10.
Fowler, Alan J., Fernando Pagán, Michaeline Hebron, et al.. (2020). 4564 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the cerebrospinal fluid of Parkinson’s patients. SHILAP Revista de lepidopterología. 4(s1). 99–99. 1 indexed citations
11.
Fowler, Alan J., Yasar Torres‐Yaghi, Fernando Pagán, et al.. (2020). Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson’s disease (5357). Neurology. 94(15_supplement). 4 indexed citations
12.
Pagán, Fernando, Michaeline Hebron, Barbara Wilmarth, et al.. (2019). Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. Pharmacology Research & Perspectives. 7(2). e00470–e00470. 73 indexed citations
13.
Matar, Sara, et al.. (2019). Parvovirus B19‐induced hemophagocytic lymphohistiocytosis: Case report and review of the literature. SHILAP Revista de lepidopterología. 7(11). 2076–2081. 10 indexed citations
14.
Pagán, Fernando, Michaeline Hebron, Barbara Wilmarth, et al.. (2019). Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease. JAMA Neurology. 77(3). 309–309. 118 indexed citations
15.
Dany, Mohammed, et al.. (2016). Advances in immunotherapy for melanoma management. Human Vaccines & Immunotherapeutics. 12(10). 2501–2511. 18 indexed citations
16.
Matar, Sara, Mohammed Dany, Saurabh Chhabra, Luciano J. Costa, & Robert K. Stuart. (2015). Pegfilgrastim 6 Mg Versus 12 Mg for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: Efficacy, Safety, and Cost Analysis. Blood. 126(23). 4306–4306. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026